Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Dezentje VO"'
Publikováno v:
Journal of Clinical Oncology; 2/1/2012, Vol. 30 Issue 4, p464-464, 1p
Autor:
Bruin MAC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mohmaed Ali MI; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. m.mohmaed@nki.nl.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. m.mohmaed@nki.nl., van Nuland M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Jacobs BAW; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lucas L; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Dezentje VO; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., de Feijter JM; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands., Bergman AM; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Publikováno v:
Pharmaceutical research [Pharm Res] 2023 Dec; Vol. 40 (12), pp. 3001-3010. Date of Electronic Publication: 2023 Oct 11.
Autor:
Vliek SB; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Noordhoek I; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Meershoek-Klein Kranenbarg E; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., van Rossum AGJ; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Dezentje VO; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Jager A; Dutch Breast Cancer Research Group, Amsterdam, the Netherlands., Hokken JWE; Department of Medical Oncology, Groene Hart Ziekenhuis, Gouda, the Netherlands., Putter H; Department of Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands., van der Velden AWG; Department of Internal Medicine, Martini Hospital, Groningen, the Netherlands., Hendriks MP; Department of Medical Oncology, Northwest Clinics, Alkmaar, the Netherlands., Bakker SD; Department of Internal Medicine, Zaans Medical Centre, Zaandam, the Netherlands., van Riet YEA; Department of Surgical Oncology, Catharina Hospital, Eindhoven, the Netherlands., Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands., Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Kroep JR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., Nortier JWR; Department of Medical Oncology, Leiden University Medical Center, Leiden, the Netherlands., van de Velde CJH; Department of Surgery, Leiden University Medical Center, Leiden, the Netherlands., Linn SC; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Sep 01; Vol. 40 (25), pp. 2934-2945. Date of Electronic Publication: 2022 Apr 20.
Autor:
Groenland SL; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands. Electronic address: s.groenland@nki.nl., van Nuland M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands., Bergman AM; Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands., de Feijter JM; Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands., Dezentje VO; Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands., Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands., Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, the Netherlands; Department of Clinical Pharmacy, University Medical Center, Utrecht University, Utrecht, the Netherlalnds., Steeghs N; Department of Clinical Pharmacology, Division of Medical Oncology, The Netherlands Cancer Institute - Antoni van Leeuwenhoek, Plesmanlaan 121, 1066 CX, Amsterdam, the Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 May; Vol. 130, pp. 32-38. Date of Electronic Publication: 2020 Mar 13.
Autor:
Sanchez-Spitman AB; a Leiden Network for Personalised Therapeutics , Leiden University Medical Center , Leiden , The Netherlands.; b Department of Clinical Pharmacy and Toxicology , Leiden University Medical Center , Leiden , The Netherlands., Swen JJ; a Leiden Network for Personalised Therapeutics , Leiden University Medical Center , Leiden , The Netherlands.; b Department of Clinical Pharmacy and Toxicology , Leiden University Medical Center , Leiden , The Netherlands., Dezentje VO; c Department of Medical Oncology , Netherlands Cancer Institute/Antoni van Leeuwenhoek , Amsterdam , The Netherlands., Moes DJAR; a Leiden Network for Personalised Therapeutics , Leiden University Medical Center , Leiden , The Netherlands.; b Department of Clinical Pharmacy and Toxicology , Leiden University Medical Center , Leiden , The Netherlands., Gelderblom H; a Leiden Network for Personalised Therapeutics , Leiden University Medical Center , Leiden , The Netherlands.; d Department of Medical Oncology , Leiden University Medical Center , Leiden , The Netherlands., Guchelaar HJ; a Leiden Network for Personalised Therapeutics , Leiden University Medical Center , Leiden , The Netherlands.; b Department of Clinical Pharmacy and Toxicology , Leiden University Medical Center , Leiden , The Netherlands.
Publikováno v:
Expert review of clinical pharmacology [Expert Rev Clin Pharmacol] 2019 Jun; Vol. 12 (6), pp. 523-536. Date of Electronic Publication: 2019 Apr 30.
Autor:
Sanchez Spitman AB; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2300, RC, The Netherlands., Moes DJAR; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2300, RC, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Dezentje VO; Department of Medical Oncology, Reinier de Graaf, Delft, The Netherlands., Swen JJ; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2300, RC, The Netherlands., Guchelaar HJ; Leiden Network for Personalised Therapeutics, Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Albinusdreef 2, Leiden, 2300, RC, The Netherlands. h.j.guchelaar@lumc.nl.
Publikováno v:
European journal of clinical pharmacology [Eur J Clin Pharmacol] 2017 Dec; Vol. 73 (12), pp. 1589-1598. Date of Electronic Publication: 2017 Aug 28.
Autor:
Opdam FL; Department of Clinical Oncology, K-1, Leiden University Medical Center, P.O. box 9600, 2300 RC Leiden, The Netherlands. f.l.opdam@lumc.nl, Dezentje VO, den Hartigh J, Modak AS, Vree R, Batman E, Smorenburg CH, Nortier JW, Gelderblom H, Guchelaar HJ
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2013 Mar; Vol. 71 (3), pp. 593-601. Date of Electronic Publication: 2012 Dec 11.